A Shared Opportunity to Transform Women’s Health

Yaso Therapeutics is advancing a unique, safe, non-hormonal contraceptive gel — an innovation with the potential to change women’s health worldwide. We are currently engaging with both strategic partners and financial investors who share our vision for accessible, equitable contraception.

For Strategic Partners

We welcome discussions with organizations interested in product distribution, licensing, or co-development. Whether you represent a global pharmaceutical company, women’s health brand, telehealth platform, or nonprofit dedicated to reproductive equity, Yaso offers a breakthrough solution that can be scaled for impact.

For Investors

Family offices, high net worth individuals, and mission-aligned venture groups are recognizing the urgency and opportunity in non-hormonal contraception. With FDA IND clearance and first-in-human trials underway, Yaso represents a de-risked, high-impact investment opportunity in women’s health innovation.

Join the Conversation

If you are an investor, potential partner, or organization interested in learning more, we would be glad to connect. Please reach out to us at:

yaso@yasotherapeutics.com

Together, we can deliver the future of safe, accessible contraception to women everywhere.